相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-NMDA receptor encephalitis, autoimmunity, and psychosis
Matthew S. Kayser et al.
SCHIZOPHRENIA RESEARCH (2016)
Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial
Peter Nagele et al.
BIOLOGICAL PSYCHIATRY (2015)
First Reported Fatalities Associated with the 'Research Chemical' 2-Methoxydiphenidine
Simon P. Elliott et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2015)
Schizophrenia drug discovery and development in an evolving era: Are new drug targets fulfilling expectations?
John Dunlop et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Glutamate and dopamine in schizophrenia: An update for the 21st century
Oliver Howes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Anesthetic Neurotoxicity - Clinical Implications of Animal Models
Bob A. Rappaport et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice
Shunsuke Takagi et al.
SCHIZOPHRENIA RESEARCH (2015)
Developing treatments for cognitive deficits in schizophrenia: The challenge of translation
J. W. Young et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Dissecting negative symptoms in schizophrenia: Opportunities for translation into new treatments
George Foussias et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Recent genetic findings in schizophrenia and their therapeutic relevance
Paul J. Harrison
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Losing Control Under Ketamine: Suppressed Cortico-Hippocampal Drive Following Acute Ketamine in Rats
Rosalyn J. Moran et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
Hiroyuki Koike et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis
Julia Deakin et al.
BIOLOGICAL PSYCHIATRY (2014)
Do Neuronal Autoantibodies Cause Psychosis? A Neuroimmunological Perspective
Ester Coutinho et al.
BIOLOGICAL PSYCHIATRY (2014)
Regulation of N-Methyl-D-Aspartate Receptors by Disrupted-in-Schizophrenia-1
Jing Wei et al.
BIOLOGICAL PSYCHIATRY (2014)
Phencyclidine Inhibits the Activity of Thalamic Reticular Gamma-Aminobutyric Acidergic Neurons in Rat Brain
Eva Troyano-Rodriguez et al.
BIOLOGICAL PSYCHIATRY (2014)
Ketamine for chronic pain: risks and benefits
Marieke Niesters et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia
David A. Lewis
CURRENT OPINION IN NEUROBIOLOGY (2014)
From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs
Hamilton Morris et al.
DRUG TESTING AND ANALYSIS (2014)
Reviewing the ketamine model for schizophrenia
Joel Frohlich et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
NMDA Antagonists for Refractory Seizures
F. A. Zeiler et al.
NEUROCRITICAL CARE (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings
Eline M. P. Poels et al.
SCHIZOPHRENIA RESEARCH (2014)
Meta-analysis of the association between N-methyl-D-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder
Daniel M. Pearlman et al.
SCHIZOPHRENIA RESEARCH (2014)
GluN2B-Containing NMDA Receptors Regulate Depression-Like Behavior and are Critical for the Rapid Antidepressant Actions of Ketamine
Oliver H. Miller et al.
ELIFE (2014)
Modulation of Adult Hippocampal Neurogenesis by Early-Life Environmental Challenges Triggering Immune Activation
Ksenia Musaelyan et al.
NEURAL PLASTICITY (2014)
Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring
T. Uchida et al.
TRANSLATIONAL PSYCHIATRY (2014)
Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy
Caroline Caddy et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)
New paradigms for treatment-resistant depression
Carlos Zarate et al.
ANNALS REPORTS (2013)
Advantages of an antagonist: bicuculline and other GABA antagonists
Graham A. R. Johnston
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: LIGAND-GATED ION CHANNELS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ION CHANNELS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: G PROTEIN-COUPLED RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study
Nicolas Gaspard et al.
EPILEPSIA (2013)
Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
Ruin Moaddel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
C. S. Weickert et al.
MOLECULAR PSYCHIATRY (2013)
The NMDA receptor as a target for cognitive enhancement
Graham L. Collingridge et al.
NEUROPHARMACOLOGY (2013)
GluN2B Antagonism Affects Interneurons and Leads to Immediate and Persistent Changes in Synaptic Plasticity, Oscillations, and Behavior
Jesse E. Hanson et al.
NEUROPSYCHOPHARMACOLOGY (2013)
CNTRICS final animal model task selection: Control of attention
C. Lustig et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Chronic ketamine produces altered distribution of parvalbumin-positive cells in the hippocampus of adult rats
Jonathan J. Sabbagh et al.
NEUROSCIENCE LETTERS (2013)
The Ketamine Analogue Methoxetamine and 3-and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor
Bryan L. Roth et al.
PLOS ONE (2013)
Magnesium in depression
Anna Serefko et al.
PHARMACOLOGICAL REPORTS (2013)
Nonhuman primate model of schizophrenia using a noninvasive EEG method
Ricardo Gil-da-Costa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain
Juan M. Lima-Ojeda et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Subanaesthetic Ketamine Treatment Alters Prefrontal Cortex Connectivity With Thalamus and Ascending Subcortical Systems
Neil Dawson et al.
SCHIZOPHRENIA BULLETIN (2013)
Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of H-1-MRS Studies
Anouk Marsman et al.
SCHIZOPHRENIA BULLETIN (2013)
NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
Melissa A. Snyder et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Rethinking schizophrenia in the context of normal neurodevelopment
Vibeke S. Catts et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Involvement of the N-methyl-D-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity
Hideko Yamamoto et al.
MOLECULAR BRAIN (2013)
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Nina V. Kraguljac et al.
JAMA PSYCHIATRY (2013)
Indistinguishable Synaptic Pharmacodynamics of the N-Methyl-D-Aspartate Receptor Channel Blockers Memantine and Ketamine
Christine M. Emnett et al.
MOLECULAR PHARMACOLOGY (2013)
Ketamine for Depression: Where Do We Go from Here?
Marije Aan Het Rot et al.
BIOLOGICAL PSYCHIATRY (2012)
Differential Role of NR2A and NR2B Subunits in N-Methyl-D-Aspartate Receptor Antagonist-Induced Aberrant Cortical Gamma Oscillations
Bernat Kocsis
BIOLOGICAL PSYCHIATRY (2012)
mTOR activation is required for the antidepressant effects of mGluR2/3 blockade
Jason M. Dwyer et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
Judith Pratt et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia
John A. Saunders et al.
NEUROBIOLOGY OF DISEASE (2012)
Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators
Daniel T. Monaghan et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Genetic mouse models relevant to schizophrenia: Taking stock and looking forward
Paul J. Harrison et al.
NEUROPHARMACOLOGY (2012)
Contributions of the D-serine pathway to schizophrenia
Viviane Labrie et al.
NEUROPHARMACOLOGY (2012)
GABAergic interneuron origin of schizophrenia pathophysiology
Kazu Nakazawa et al.
NEUROPHARMACOLOGY (2012)
Signaling pathways underlying the rapid antidepressant actions of ketamine
Ronald S. Duman et al.
NEUROPHARMACOLOGY (2012)
Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia
Susan B. Powell et al.
NEUROPHARMACOLOGY (2012)
NMDA receptors, cognition and schizophrenia - Testing the validity of the NMDA receptor hypofunction hypothesis
Gary Gilmour et al.
NEUROPHARMACOLOGY (2012)
Prenatal NMDA Receptor Antagonism Impaired Proliferation of Neuronal Progenitor, Leading to Fewer Glutamatergic Neurons in the Prefrontal Cortex
Kazuya Toriumi et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Twenty-five Years of Glutamate in Schizophrenia: Are We There Yet?
Daniel C. Javitt
SCHIZOPHRENIA BULLETIN (2012)
Phencyclidine/Schizophrenia: One View Toward the Past, The Other to the Future
Edward F. Domino et al.
SCHIZOPHRENIA BULLETIN (2012)
Capturing the Angel in Angel Dust: Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans
Bita Moghaddam et al.
SCHIZOPHRENIA BULLETIN (2012)
NMDA Receptor and Schizophrenia: A Brief History
Joseph T. Coyle
SCHIZOPHRENIA BULLETIN (2012)
Epigenetics of major psychosis: progress, problems and perspectives
Viviane Labrie et al.
TRENDS IN GENETICS (2012)
NMDA receptor regulates migration of newly generated neurons in the adult hippocampus via Disrupted-In-Schizophrenia 1 (DISC1)
Takashi Namba et al.
JOURNAL OF NEUROCHEMISTRY (2011)
COMPLEX RECEPTOR MEDIATION OF ACUTE KETAMINE APPLICATION ON IN VITRO GAMMA OSCILLATIONS IN MOUSE PREFRONTAL CORTEX: MODELING GAMMA BAND OSCILLATION ABNORMALITIES IN SCHIZOPHRENIA
J. M. McNally et al.
NEUROSCIENCE (2011)
Preclinical Evidence Toward the Use of Ketamine for Recombinant Tissue-Type Plasminogen Activator-Mediated Thrombolysis Under Anesthesia or Sedation
Clement Gakuba et al.
STROKE (2011)
A Systematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury
Robert W. Teasell et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2010)
Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABAA receptor binding
Richard J. Beninger et al.
BEHAVIOURAL PHARMACOLOGY (2010)
Disruption of Performance in the Five-Choice Serial Reaction Time Task Induced By Administration of N-Methyl-D-Aspartate Receptor Antagonists: Relevance to Cognitive Dysfunction in Schizophrenia
Nurith Amitai et al.
BIOLOGICAL PSYCHIATRY (2010)
Mouse behavioral endophenotypes for schizophrenia
Laura C. Amann et al.
BRAIN RESEARCH BULLETIN (2010)
Neuroprotection by Ketamine: A Review of the Experimental and Clinical Evidence
Judith A. Hudetz et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2010)
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
Juan E. Belforte et al.
NATURE NEUROSCIENCE (2010)
Long-term depression in the CNS
Graham L. Collingridge et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Abnormal neural oscillations and synchrony in schizophrenia
Peter J. Uhlhaas et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Gamma Oscillatory Power is Impaired During Cognitive Control Independent of Medication Status in First-Episode Schizophrenia
Michael J. Minzenberg et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Essential Role of NMDA Receptor Channel ε4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine
Yoko Hagino et al.
PLOS ONE (2010)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists
Jerry J. Buccafusco et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade
Teresa Marie du Bois et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine
Xiangdong Chen et al.
JOURNAL OF NEUROSCIENCE (2009)
Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
Shawn E. Kotermanski et al.
JOURNAL OF NEUROSCIENCE (2009)
HCN1 channels constrain DHPG-induced LTD at hippocampal Schaffer collateral-CA1 synapses
Tursonjan Tokay et al.
LEARNING & MEMORY (2009)
Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors
Kate E. Gilling et al.
NEUROPHARMACOLOGY (2009)
DIFFERENTIAL ROLE OF N-METHYL-D-ASPARTATE RECEPTOR SUBUNITS 2A AND 2B IN MEDIATING PHENCYCLIDINE-INDUCED PERINATAL NEURONAL APOPTOSIS AND BEHAVIORAL DEFICITS
N. C. Anastasio et al.
NEUROSCIENCE (2009)
N-METHYL-D-ASPARTIC ACID RECEPTOR ANTAGONIST-INDUCED FREQUENCY OSCILLATIONS IN MICE RECREATE PATTERN OF ELECTROPHYSIOLOGICAL DEFICITS IN SCHIZOPHRENIA
R. S. Ehrlichman et al.
NEUROSCIENCE (2009)
Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat-a back translational study
Pascal Goetghebeur et al.
PSYCHOPHARMACOLOGY (2009)
Dopamine D2High Receptors Stimulated by Phencyclidines, Lysergic Acid Diethylamide, Salvinorin A, and Modafinil
Philip Seeman et al.
SYNAPSE (2009)
Evaluation of a neurodevelopmental model of schizophrenia - Early postnatal PCP treatment in attentional set-shifting
Brian Villumsen Broberg et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
The destruction of the lower urinary tract by ketamine abuse: a new syndrome?
Peggy Sau-Kwan Chu et al.
BJU INTERNATIONAL (2008)
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
Sheldon H. Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Urine drug screening: Practical guide for clinicians
Karen E. Moeller et al.
MAYO CLINIC PROCEEDINGS (2008)
Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats
Alice Egerton et al.
PSYCHOPHARMACOLOGY (2008)
Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
Karsten Heekeren et al.
PSYCHOPHARMACOLOGY (2008)
Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia
Anita K. Roopun et al.
SCHIZOPHRENIA BULLETIN (2008)
Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons
Cheng Z. Wang et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: Comparison among antipsychotics
Joshua S. Rodefer et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase
M. Margarita Behrens et al.
SCIENCE (2007)
The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101 606 in rats and rhesus monkeys
Katherine L. Nicholson et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
Repeated phencyclidine in monkeys results in loss of parvalbumin-containing axo-axonic projections in the prefrontal cortex
Bret A. Morrow et al.
PSYCHOPHARMACOLOGY (2007)
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block
Shashank M. Dravid et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients
David L. Braff et al.
BIOLOGICAL PSYCHIATRY (2007)
Ketamine-associated ulcerative cystitis: A new clinical entity
Rohan Shahani et al.
UROLOGY (2007)
Low dose ketamine: a therapeutic and research tool to explore N-methyt-Daspartate (NMDA) receptor-mediated plasticity in pain pathways
Boris A. Chizh
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Development of a rational scale to assess the harm of drugs of potential misuse
David Nutt et al.
LANCET (2007)
Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidine
Kenji Maeda et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus
Thomas E. Bartlett et al.
NEUROPHARMACOLOGY (2007)
Impairments in frontal cortical γ synchrony and cognitive control in schizophrenia
R. Y. Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats
Takao Yoshimizu et al.
PSYCHOPHARMACOLOGY (2006)
A role for AMPA receptors in mood disorders
A Alt et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness
MO Cunningham et al.
JOURNAL OF NEUROSCIENCE (2006)
Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists
KW Muir
CURRENT OPINION IN PHARMACOLOGY (2006)
Pathophysiologically based treatment interventions in schizophrenia
David A. Lewis et al.
NATURE MEDICINE (2006)
Mismatch negativity in schizophrenia: a meta-analysis
D Umbricht et al.
SCHIZOPHRENIA RESEARCH (2005)
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects
JH Krystal et al.
PSYCHOPHARMACOLOGY (2005)
PCP: from pharmacology to modelling schizophrenia
BJ Morris et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
PJ Harrison et al.
MOLECULAR PSYCHIATRY (2005)
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity
S Chaki et al.
NEUROPHARMACOLOGY (2004)
Increased neurogenesis in a rat ketamine model of schizophrenia
G Keilhoff et al.
BIOLOGICAL PSYCHIATRY (2004)
Calcium binding protein markers of GABA deficits in schizophrenia - Post mortem studies and animal models
GP Reynolds et al.
NEUROTOXICITY RESEARCH (2004)
The role of monoamines in the actions of established and novel antidepressant agents: a critical review
MJ Millan
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Ca2+ imaging of mouse neocortical interneurone dendrites:: Contribution of Ca2+-permeable AMPA and NMDA receptors to subthreshold Ca2+ dynamics
JH Goldberg et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Enhancement of antidepressant potency by a potentiator of AMPA receptors
X Li et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2003)
Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine
J De Vry et al.
BEHAVIOURAL PHARMACOLOGY (2003)
Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: Differential modulation by antipsychotic drugs
SM Cochran et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268
DS Lorrain et al.
NEUROSCIENCE (2003)
Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia
DW Volk et al.
CEREBRAL CORTEX (2002)
Channel blockers acting at N-methyl-D-aspartate receptors: Differential effects of mutations in the vestibule and ion channel pore
K Kashiwagi et al.
MOLECULAR PHARMACOLOGY (2002)
Effects of ketamine in normal and schizophrenic volunteers
AC Lahti et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
MA Geyer et al.
PSYCHOPHARMACOLOGY (2001)
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
X Li et al.
NEUROPHARMACOLOGY (2001)
Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: Implications for schizophrenia
C Wang et al.
NEUROSCIENCE (2001)
Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder -: A postmortem brain study
A Guidotti et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Stereospecific interaction of ketamine with nicotinic acetylcholine receptors in human sympathetic ganglion-like SH-SY5Y cells
P Friederich et al.
ANESTHESIOLOGY (2000)
Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine
T Yamakura et al.
ANESTHESIOLOGY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Selfotel in acute ischemic stroke - Possible neurotoxic effects of an NMDA antagonist
SM Davis et al.
STROKE (2000)
分享论文
